article thumbnail

Apellis flags needle problems in hunt for Syfovre side effect source

Fierce Pharma

While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre.

article thumbnail

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

Fierce Pharma

But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Organon's prolific asthma med Singulair needs new safety labeling, NY attorney general argues

Fierce Pharma

Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns about the drug’s neuropsychiatric side ef | Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns (..)

article thumbnail

Apellis attempts to clear the air around Syfovre safety as eye drug launch gains steam

Fierce Pharma

For Apellis Pharmaceuticals, the emergence of rare but serious side effects has cast a pall over the launch of the company’s geographic atrophy med Syfovre. While touting the “strong commercial execution” of Syfovre’s launch, Apellis’ CEO Cedric Francois, M.D.,

article thumbnail

Thursday pharma headlines

World of DTC Marketing

The company decided there were too few reports of serious depression and suicidal behavior and not enough specifics about those cases to warrant more than “routine” monitoring of safety data. The national vaccine safety surveillance program run by the Centers for Disease Control and Prevention (CDC) and the U.S. COVID Dashboards.

Pharma 180
article thumbnail

Unfair balance

World of DTC Marketing

I just finished an analysis of a pharma clients website using their analytics. While the product safety information page is among the top five pages visited what alarmed me was that time on the page was measured in seconds not minutes for most online visitors. For some reason, the FDA still requires fair balance on website home pages.

article thumbnail

Elements of a great pharma website

World of DTC Marketing

6ix: Safety information needs context. In clinical trials, how many people experienced a listed side effect? 9ine: “Why aren’t pharma websites updated?” Our groups thought pharma websites had a lot of credibility especially when our moderator informed them that the website had been approved by the FDA.

Pharma 180